271 related articles for article (PubMed ID: 27339904)
21. P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells.
Toscano F; Fajoui ZE; Gay F; Lalaoui N; Parmentier B; Chayvialle JA; Scoazec JY; Micheau O; Abello J; Saurin JC
Oncogene; 2008 Jul; 27(30):4161-71. PubMed ID: 18345033
[TBL] [Abstract][Full Text] [Related]
22. TNF-related apoptosis-inducing ligand cooperates with NSAIDs via activated Wnt signalling in (pre)malignant colon cells.
Heijink DM; Jalving M; Oosterhuis D; Sloots IA; Koster R; Hollema H; Kleibeuker JH; Koornstra JJ; de Vries EG; de Jong S
J Pathol; 2011 Feb; 223(3):378-89. PubMed ID: 21171083
[TBL] [Abstract][Full Text] [Related]
23. Nutlin-3, a small-molecule MDM2 inhibitor, sensitizes Caki cells to TRAIL-induced apoptosis through p53-mediated PUMA upregulation and ROS-mediated DR5 upregulation.
Park EJ; Choi KS; Yoo YH; Kwon TK
Anticancer Drugs; 2013 Mar; 24(3):260-9. PubMed ID: 23187459
[TBL] [Abstract][Full Text] [Related]
24. Reversal of Mutant KRAS-Mediated Apoptosis Resistance by Concurrent Noxa/Bik Induction and Bcl-2/Bcl-xL Antagonism in Colon Cancer Cells.
Okamoto K; Zaanan A; Kawakami H; Huang S; Sinicrope FA
Mol Cancer Res; 2015 Apr; 13(4):659-69. PubMed ID: 25548100
[TBL] [Abstract][Full Text] [Related]
25. Apoptosis primarily accounts for the growth-inhibitory properties of sulindac metabolites and involves a mechanism that is independent of cyclooxygenase inhibition, cell cycle arrest, and p53 induction.
Piazza GA; Rahm AK; Finn TS; Fryer BH; Li H; Stoumen AL; Pamukcu R; Ahnen DJ
Cancer Res; 1997 Jun; 57(12):2452-9. PubMed ID: 9192825
[TBL] [Abstract][Full Text] [Related]
26. Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL.
Ravi R; Jain AJ; Schulick RD; Pham V; Prouser TS; Allen H; Mayer EG; Yu H; Pardoll DM; Ashkenazi A; Bedi A
Cancer Res; 2004 Dec; 64(24):9105-14. PubMed ID: 15604280
[TBL] [Abstract][Full Text] [Related]
27. Synergistic induction of apoptosis by sulindac and arsenic trioxide in human lung cancer A549 cells via reactive oxygen species-dependent down-regulation of survivin.
Jin HO; Yoon SI; Seo SK; Lee HC; Woo SH; Yoo DH; Lee SJ; Choe TB; An S; Kwon TJ; Kim JI; Park MJ; Hong SI; Park IC; Rhee CH
Biochem Pharmacol; 2006 Nov; 72(10):1228-36. PubMed ID: 16950207
[TBL] [Abstract][Full Text] [Related]
28. Docosahexaenoic acid sensitizes colon cancer cells to sulindac sulfide-induced apoptosis.
Lim SJ; Lee E; Lee EH; Kim SY; Cha JH; Choi H; Park W; Choi HK; Ko SH; Kim SH
Oncol Rep; 2012 Jun; 27(6):2023-30. PubMed ID: 22395735
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-203 induces apoptosis by upregulating Puma expression in colon and lung cancer cells.
Funamizu N; Lacy CR; Kamada M; Yanaga K; Manome Y
Int J Oncol; 2015 Nov; 47(5):1981-8. PubMed ID: 26397233
[TBL] [Abstract][Full Text] [Related]
30. Improving anticancer activity towards colon cancer cells with a new p53-activating agent.
Raimundo L; Espadinha M; Soares J; Loureiro JB; Alves MG; Santos MMM; Saraiva L
Br J Pharmacol; 2018 Oct; 175(20):3947-3962. PubMed ID: 30076608
[TBL] [Abstract][Full Text] [Related]
31. Sulindac enhances the proteasome inhibitor bortezomib-mediated oxidative stress and anticancer activity.
Minami T; Adachi M; Kawamura R; Zhang Y; Shinomura Y; Imai K
Clin Cancer Res; 2005 Jul; 11(14):5248-56. PubMed ID: 16033843
[TBL] [Abstract][Full Text] [Related]
32. Protoporphyrin IX interacts with wild-type p53 protein in vitro and induces cell death of human colon cancer cells in a p53-dependent and -independent manner.
Zawacka-Pankau J; Issaeva N; Hossain S; Pramanik A; Selivanova G; Podhajska AJ
J Biol Chem; 2007 Jan; 282(4):2466-72. PubMed ID: 17135250
[TBL] [Abstract][Full Text] [Related]
33. Reactive oxygen species up-regulate p53 and Puma; a possible mechanism for apoptosis during combined treatment with TRAIL and wogonin.
Lee DH; Rhee JG; Lee YJ
Br J Pharmacol; 2009 Aug; 157(7):1189-202. PubMed ID: 19438509
[TBL] [Abstract][Full Text] [Related]
34. 5-Aza-2'-deoxycytidine restores proapoptotic function of p53 in cancer cells resistant to p53-induced apoptosis.
Yagi S; Oda-Sato E; Uehara I; Asano Y; Nakajima W; Takeshita T; Tanaka N
Cancer Invest; 2008 Aug; 26(7):680-8. PubMed ID: 18608210
[TBL] [Abstract][Full Text] [Related]
35. PUMA mediates the combinational therapy of 5-FU and NVP-BEZ235 in colon cancer.
Wang H; Zhang L; Yang X; Jin Y; Pei S; Zhang D; Zhang H; Zhou B; Zhang Y; Lin D
Oncotarget; 2015 Jun; 6(16):14385-98. PubMed ID: 25965911
[TBL] [Abstract][Full Text] [Related]
36. Novel p53-dependent anticancer strategy by targeting iron signaling and BNIP3L-induced mitophagy.
Wilfinger N; Austin S; Scheiber-Mojdehkar B; Berger W; Reipert S; Praschberger M; Paur J; Trondl R; Keppler BK; Zielinski CC; Nowikovsky K
Oncotarget; 2016 Jan; 7(2):1242-61. PubMed ID: 26517689
[TBL] [Abstract][Full Text] [Related]
37. The BH3-only protein, PUMA, is involved in oxaliplatin-induced apoptosis in colon cancer cells.
Wang X; Li M; Wang J; Yeung CM; Zhang H; Kung HF; Jiang B; Lin MC
Biochem Pharmacol; 2006 May; 71(11):1540-50. PubMed ID: 16595125
[TBL] [Abstract][Full Text] [Related]
38. Sp1 is involved in H2O2-induced PUMA gene expression and apoptosis in colorectal cancer cells.
Wang X; Wang J; Lin S; Geng Y; Wang J; Jiang B
J Exp Clin Cancer Res; 2008 Sep; 27(1):44. PubMed ID: 18811981
[TBL] [Abstract][Full Text] [Related]
39. Sulindac sulfide-induced apoptosis involves death receptor 5 and the caspase 8-dependent pathway in human colon and prostate cancer cells.
Huang Y; He Q; Hillman MJ; Rong R; Sheikh MS
Cancer Res; 2001 Sep; 61(18):6918-24. PubMed ID: 11559570
[TBL] [Abstract][Full Text] [Related]
40. Selenomethionine induces p53 mediated cell cycle arrest and apoptosis in human colon cancer cells.
Goel A; Fuerst F; Hotchkiss E; Boland CR
Cancer Biol Ther; 2006 May; 5(5):529-35. PubMed ID: 16627976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
